# Liposome Bupivacaine Interscalene Total Shoulder

> **NCT03587636** · PHASE2 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 77 (actual)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** liposome bupivacaine
- **DRUG:** Bupivacaine

## Key facts

- **NCT ID:** NCT03587636
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-17
- **Primary completion:** 2021-03-15
- **Final completion:** 2021-03-17
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2022-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03587636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03587636, "Liposome Bupivacaine Interscalene Total Shoulder". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT03587636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*